Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
and apoptotic ratio compared with those in the IR+Mel group
and SUN concentrations and renal caspase 3/7 activity decreased in 5/6Nx mice treated with NS-03-08
No significant weight loss occurs in cambinol-treated animals relative to controls
Formula: C17H30Br2N2
Ranolazine-d8 H-PEG4-CH2COOH and apoptotic ratio compared withRanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.